US2020292531A1PendingUtilityA1
Methods, Systems, And Compositions For Determining Blood Clot Formation, And Uses Thereof
Est. expiryMay 22, 2035(~8.8 yrs left)· nominal 20-yr term from priority
Inventors:Donald E. IngberAbhishek JainAndries Van Der MeerAlan D. MichelsonAndrew L. Frelinger, IiiRiccardo Barrile
G01N 2800/226G01N 33/86G01N 33/48B01L 3/5027G01N 33/5064C12Q 1/56G01N 33/5032
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method is directed to determining a thrombosis function and includes flowing a fluid sample over a surface having a fixed endothelial cell monolayer. The method further includes stimulating the fixed endothelial cell monolayer to induce formation of a clot, the clot being formed via interaction between the fixed endothelial cell monolayer and the fluid sample. In response to the clot formation, the method further includes determining a thrombosis function associated with the fluid sample and the fixed endothelial cell monolayer.
Claims
exact text as granted — not AI-modified1 - 65 . (canceled)
66 . A method of making microfluidic devices, comprising:
a) providing a microfluidic device comprising a channel; b) culturing endothelial cells in the channel so as to form a lumen; c) fixing the endothelial cells; and d) shipping the device.
67 . The method of claim 66 , wherein the fixing is done with a fixative agent selected from the group consisting of formaldehyde, paraformaldehyde, formalin, glutaraldehyde, mercuric chloride-based fixatives, Helly's solution, Zeneker's solution, precipitating fixatives, ethanol, methanol, acetone, dimethyl suberimidate, Bouin's fixative, a decellularization solvent, a detergent, a high pH solution, and a combination of two or more thereof.
68 . The method of claim 66 , wherein the method further comprises the step of storing the microfluidic device after step c).
69 . The method of claim 68 , wherein the microfluidic device is stored at a temperature between 4° C. and 10° C.
70 . The method of claim 68 , wherein the microfluidic device is stored at a temperature of about 4° C. or lower.
71 . The method of claim 68 , wherein the microfluidic device is stored at room temperature.
72 . The method of claim 68 , wherein the microfluidic device is stored for 1 day or longer.
73 . The method of claim 68 , wherein the microfluidic device is stored for 5 days or longer.
74 . A method of making microfluidic devices, comprising:
a) providing a microfluidic device comprising a channel; b) culturing endothelial cells in the channel of each microfluidic device so as to form a lumen; c) fixing the endothelial cells; and d) storing the plurality of microfluidic devices.
75 . The method of claim 74 , wherein the fixing is done with a fixative agent selected from the group consisting of formaldehyde, paraformaldehyde, formalin, glutaraldehyde, mercuric chloride-based fixatives, Helly's solution, Zeneker's solution, precipitating fixatives, ethanol, methanol, acetone, dimethyl suberimidate, Bouin's fixative, a decellularization solvent, a detergent, a high pH solution, and a combination of two or more thereof.
76 . The method of claim 74 , wherein the microfluidic device is stored at a temperature between 4° C. and 10° C.
77 . The method of claim 74 , wherein the microfluidic device is stored at a temperature of about 4° C. or lower.
78 . The method of claim 74 , wherein the microfluidic device is stored at room temperature.
79 . The method of claim 74 , wherein the microfluidic device is stored for 1 day or longer.
80 . The method of claim 74 , wherein the microfluidic device is stored for 5 days or longer.Join the waitlist — get patent alerts
Track US2020292531A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.